Lexitas

Lexitas is a privately held, revenue-generating service provider operating as a premier ophthalmology-focused CRO. It leverages over 475 years of combined team experience in ophthalmology and clinical research to offer tailored, full-service support from study design through execution and analysis. The company's integrated model, which includes a dedicated reading center, positions it as a specialized partner for biotech and pharma companies developing novel eye care treatments. Its client base includes a range of companies from small biotechs to more established entities, as evidenced by numerous positive testimonials.

Integrated ophthalmology clinical research organization (CRO) with a proprietary operational framework and a dedicated, centralized Reading Center for ophthalmic image analysis. The platform encompasses end-to-end clinical trial services tailored specifically for eye disease studies.

Lexitas competes in the specialized ophthalmology CRO segment against other focused players and the ophthalmology divisions of large, global full-service CROs (e.g., IQVIA, PPD, Parexel). Its differentiation lies in its exclusive ophthalmology focus, integrated reading center, and emphasis on personalized, collaborative partnerships, particularly appealing to small and mid-sized biotech sponsors.